english.prescrire.org > Annual Prescrire Awards > The Prescrire Awards for 2008 > The 2008 Prescrire Drug Awards
The Prescrire Awards for 2008

The independent French journal's take on the year's
top Drugs, Packaging and Information

The 2008 Prescrire Drug Awards

In 2008, for the first time since the Drug Awards began in 1981, no drugs have been awarded the Golden Pill or mentioned on the Honours List.

The Prescrire Drug Awards focus on products evaluated during the previous year in the New Products section of Prescrire's French edition (issues 291 to 302 in 2008).

In 2008, for the first time since the Prescrire Drug Awards began in 1981, no drugs have been awarded the Golden Pill or mentioned on the Honours List.

 

PILULE D'OR / GOLDEN PILL
The “Golden Pill” award is granted to drugs that provide a major therapeutic advance in a field in which no effective treatment was previously available.
NOT ATTRIBUTED IN 2008
HONOURS LIST
The drugs included on the Honours List provide a clear advantage for some patients in comparison to existing therapeutic options, albeit with certain limitations.
NO INCLUSIONS IN 2008
NOTEWORTHY
The following drugs (in alphabetical order of their international nonproprietary names (INN), the drug’s real name) made a modest contribution to patient care:
metformin METFORMIN MERCK° dispersible tablets Mylan 1st liquid oral form, as a dispersible tablet, of an essential drug for type 2 diabetes (Prescrire International 96)
methadone MÉTHADONE AP-HP° capsules
Bouchara-Recordati		 1st dry oral form (capsules) of opioid replacement therapy for opioid dependence, for patients already established on the oral solution form (la revue Prescrire 295 and coming in Prescrire International)
urokinase ACTOSOLV° Eumedica to clear thrombosed central venous catheters or dialysis catheters, after failure of heparin (la revue Prescrire 302 and coming in Prescrire International)
©Prescrire April 2009
Source: Prescrire Int 2009; 18 (100): 81.